Viking shares fell on Phase 2 obesity pill data as tolerability issues surfaced, but William Blair says the stock’s sell-off is excessive.
Latest Ratings for VKTX
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 2022 | Raymond James | Maintains | Outperform | |
| Jul 2021 | Raymond James | Maintains | Outperform | |
| May 2021 | Raymond James | Downgrades | Strong Buy | Outperform |
